These cytogenetic and molecular findings have led to the WHO 2016 classification in which oligodendrogliomas have a strict molecular definition displaying an IDH (Isocitrate dehydrogenase) alteration and evidence for deletion of both 1p and 19q for an integrated diagnosis [4,23,24,25]. The gene discussed is IDH2; the disease is oligodendroglioma.